Zobrazeno 1 - 10
of 30
pro vyhledávání: '"N. F. Pravdina"'
Publikováno v:
Voprosy virusologii. 36(2)
Publikováno v:
Molekuliarnaia genetika, mikrobiologiia i virusologiia. (11)
Publikováno v:
Bulletin of Experimental Biology and Medicine. 99:90-92
A sarcolysine-resistant strain of mouse plasmacytoma MOPC/406 was obtained in experiments on 250 BALB/c mice. The initial plasmacytoma strain is highly sensitive to sarcolysine. When administered in doses of 10 and 5 mg/kg it increases the lifespan u
Publikováno v:
Voprosy virusologii. (1)
The activity and properties of RNA-dependent RNA-polymerase in cells infected with Venezuelan equine encephalomyelitis virus were studied. The maximum activity of the enzyme was found 4-5 hours after infection. The effect of two synthetic drugs (rima
Publikováno v:
Biokhimiia (Moscow, Russia). 44(6)
The properties of RNA polymerases A, B and C isolated from the spleens of mice infected with Rauscher leukemic virus were studied. The solubilized RNA-polymerases A and B were purified 150--300-fold. The dynamic changes in the activities of all forms
Publikováno v:
Molekuliarnaia genetika, mikrobiologiia i virusologiia. (3)
Publikováno v:
Biofizika. 26(3)
Results are presented of 3H-labelling of antivirus preparations amantadine and rimantadine. They show possible application of 3H-amantadine and 3H-rimantadine obtained in virological investigations.
Publikováno v:
Voprosy virusologii. 29(2)
The transcriptase activity of original mouse-apathogenic strains of human (A/USSR/05/81) and animal (A/walrus/Massachusetts/1/80) influenza viruses and their pathogenic variants was studied. Also RNA-polymerase was studied in two types of antigenic r
Publikováno v:
Molekuliarnaia genetika, mikrobiologiia i virusologiia. (1)
Some new analogues of ribonucleoside-5'-triphosphates modified in 3'-ribose position and base [CTP (3'NH2), CTP (3'NH2) (5Me), CTP (3'N3) (5 Me), RvTP (3'N3)] have been synthesized. The inhibitions of RNA-synthesis catalyzed by the influenza A viral
Publikováno v:
Voprosy virusologii. 34(5)